Ataxia
Gene: C17orf80
PMID 41720819 reports 3 individuals from 2 unrelated families with biallelic MTNAP1 variants (hmz missense and hmz LoF) presenting with early‑onset global developmental delay, ataxia, spasticity, seizures and progressive cerebral and cerebellar atrophy. Functional studies in proband-derived fibroblasts and MTNAP1-silenced neuronal cells implicated profound mitochondrial fragmentation, reduced oxidative phosphorylation capacity, increased reactive oxygen species accumulation, and premature senescence-like stress responses. Structural modeling and biophysical analyses revealed that the p.G553R variant destabilizes the MTNAP1 fold, disrupts its DNA- and membrane-binding interfaces, and induces aberrant aggregation, leading to loss of mitochondrial integrity.
Sources: LiteratureCreated: 13 Mar 2026, 5:30 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Mitochondrial disease, MONDO:0044970
Publications
Gene: c17orf80 has been classified as Amber List (Moderate Evidence).
gene: C17orf80 was added gene: C17orf80 was added to Ataxia. Sources: Expert Review Amber,Literature new gene name tags were added to gene: C17orf80. Mode of inheritance for gene: C17orf80 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: C17orf80 were set to 41720819 Phenotypes for gene: C17orf80 were set to Mitochondrial disease, MONDO:0044970